Geneos Wealth Management’s Baxter International BAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.5K Sell
684
-20
-3% -$387 ﹤0.01% 1950
2025
Q4
$13.5K Buy
704
+5
+0.7% +$100 ﹤0.01% 1871
2025
Q3
$15.9K Sell
699
-78
-10% -$1.98K ﹤0.01% 1814
2025
Q2
$23.5K Sell
777
-566
-42% -$17.2K ﹤0.01% 1955
2025
Q1
$84.2K Buy
1,343
+513
+62% +$16.8K ﹤0.01% 1661
2024
Q4
$24.2K Sell
830
-341
-29% -$11.5K ﹤0.01% 1630
2024
Q3
$44.5K Buy
1,171
+897
+327% +$33K ﹤0.01% 1241
2024
Q2
$9.16K Buy
274
+52
+23% +$1.92K ﹤0.01% 1569
2024
Q1
$9.49K Buy
222
+5
+2% +$203 ﹤0.01% 1555
2023
Q4
$8.39K Buy
217
+22
+11% +$778 ﹤0.01% 1590
2023
Q3
$7.36K Buy
195
+10
+5% +$426 ﹤0.01% 1643
2023
Q2
$8.43K Hold
185
﹤0.01% 1619
2023
Q1
$7.5K Buy
185
+164
+781% +$6.95K ﹤0.01% 1622
2022
Q4
$1.07K Buy
21
+4
+24% +$215 ﹤0.01% 1956
2022
Q3
$0 Sell
17
-2,663
-99% -$160K ﹤0.01% 2050
2022
Q2
$175K Sell
2,680
-37
-1% -$2.69K 0.01% 790
2022
Q1
$210K Sell
2,717
-941
-26% -$78.8K 0.01% 783
2021
Q4
$314K Buy
3,658
+677
+23% +$54.5K 0.01% 720
2021
Q3
$242K Buy
2,981
+79
+3% +$6.24K 0.01% 789
2021
Q2
$237K Sell
2,902
-302
-9% -$25.3K 0.01% 779
2021
Q1
$274K Hold
3,204
0.01% 840
2020
Q4
$248K Sell
3,204
-107
-3% -$8.48K 0.01% 756
2020
Q3
$263K Sell
3,311
-1,084
-25% -$91.2K 0.01% 599
2020
Q2
$370K Buy
4,395
+200
+5% +$17.4K 0.02% 482
2020
Q1
$334K Buy
4,195
+920
+28% +$79.4K 0.02% 467
2019
Q4
$275K Hold
3,275
0.01% 584
2019
Q3
$281K Sell
3,275
-74
-2% -$6.32K 0.02% 549
2019
Q2
$274K Hold
3,349
0.02% 571
2019
Q1
$272K Sell
3,349
-2,637
-44% -$192K 0.02% 559
2018
Q4
$390K Buy
5,986
+2,971
+99% +$200K 0.03% 426
2018
Q3
$232K Sell
3,015
-33
-1% -$2.45K 0.02% 586
2018
Q2
$225K Hold
3,048
0.02% 539
2018
Q1
$198K Sell
3,048
-150
-5% -$10.1K 0.02% 543
2017
Q4
$206K Sell
3,198
-190
-6% -$12.2K 0.02% 527
2017
Q3
$212K Buy
3,388
+1
+0% +$62 0.02% 493
2017
Q2
$205K Buy
3,387
+102
+3% +$5.79K 0.02% 490
2017
Q1
$170K Sell
3,285
-95
-3% -$4.67K 0.02% 521
2016
Q4
$149K Sell
3,380
-1,025
-23% -$47.4K 0.02% 522
2016
Q3
$209K Buy
4,405
+157
+4% +$7.4K 0.03% 437
2016
Q2
$193K Sell
4,248
-47
-1% -$2.06K 0.03% 452
2016
Q1
$179K Buy
+4,295
New +$164K 0.03% 456

Other funds holding BAX

Geneos Wealth Management's BAX Position: Q1 2026 in Review

Geneos Wealth Management reduced its Baxter International (BAX) stake by 2.8% in Q1 2026, selling an estimated $387 and leaving 684 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1950.

Geneos Wealth Management first reported a position in BAX in Q1 2016 and has held it in 41 quarters since. The position peaked at $390K in Q4 2018. 657 funds tracked by Wall St. Rank hold BAX as of Q1 2026.

  • Geneos Wealth Management held 684 shares of Baxter International worth $11.5K as of Q1 2026.
  • Geneos Wealth Management sold 20 Baxter International shares in Q1 2026, an estimated $387.
  • Baxter International made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1950 holding.
  • Geneos Wealth Management first reported a position in Baxter International in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Baxter International position peaked at $390K in Q4 2018.
  • 657 funds tracked by Wall St. Rank held Baxter International as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.